How is adult rhabdoid renal cell carcinoma (RRCC) differentiated from pediatric malignant rhabdoid rumor (MRT)?

1. Lopez-Beltran A, Scarpelli M, Montironi R, Kirkali Z. 2004 WHO classification of the renal tumors of the adults. Eur Urol. 2006 May. 49(5):798-805. [Medline].

2. Kanamaru H, Sasaki M, Miwa Y, Akino H, Okada K. Prognostic value of sarcomatoid histology and volume-weighted mean nuclear volume in renal cell carcinoma. BJU Int. 1999 Feb. 83(3):222-6. [Medline].

3. Mian BM, Bhadkamkar N, Slaton JW, Pisters PW, Daliani D, Swanson DA, et al. Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma. J Urol. 2002 Jan. 167(1):65-70. [Medline].

4. Cheville JC, Lohse CM, Zincke H, Weaver AL, Leibovich BC, Frank I, et al. Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol. 2004 Apr. 28(4):435-41. [Medline].

5. Tickoo SK, Alden D, Olgac S, Fine SW, Russo P, Kondagunta GV, et al. Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma. J Urol. 2007 Apr. 177(4):1258-63. [Medline].

6. Kuroiwa K, Konomoto T, Kumazawa J, Naito S, Tsuneyoshi M. Cell proliferative activity and expression of cell-cell adhesion factors (E-cadherin, alpha-, beta-, and gamma-catenin, and p120) in sarcomatoid renal cell carcinoma. J Surg Oncol. 2001 Jun. 77(2):123-31. [Medline].

7. de Peralta-Venturina M, Moch H, Amin M, Tamboli P, Hailemariam S, Mihatsch M, et al. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am J Surg Pathol. 2001 Mar. 25(3):275-84. [Medline].

8. Gökden N, Nappi O, Swanson PE, Pfeifer JD, Vollmer RT, Wick MR, et al. Renal cell carcinoma with rhabdoid features. Am J Surg Pathol. 2000 Oct. 24(10):1329-38. [Medline].

9. Kuroiwa K, Kinoshita Y, Shiratsuchi H, Oshiro Y, Tamiya S, Oda Y, et al. Renal cell carcinoma with rhabdoid features: an aggressive neoplasm. Histopathology. 2002 Dec. 41(6):538-48. [Medline].

10. Leroy X, Zini L, Buob D, Ballereau C, Villers A, Aubert S. Renal cell carcinoma with rhabdoid features: an aggressive neoplasm with overexpression of p53. Arch Pathol Lab Med. 2007 Jan. 131(1):102-6. [Medline].

11. Peng HQ, Stanek AE, Teichberg S, Shepard B, Kahn E. Malignant rhabdoid tumor of the kidney in an adult: a case report and review of the literature. Arch Pathol Lab Med. 2003 Sep. 127(9):e371-3. [Medline].

12. Schofield DE, Beckwith JB, Sklar J. Loss of heterozygosity at chromosome regions 22q11-12 and 11p15.5 in renal rhabdoid tumors. Genes Chromosomes Cancer. 1996 Jan. 15(1):10-7. [Medline].

13. Fuller CE, Pfeifer J, Humphrey P, Bruch LA, Dehner LP, Perry A. Chromosome 22q dosage in composite extrarenal rhabdoid tumors: clonal evolution or a phenotypic mimic?. Hum Pathol. 2001 Oct. 32(10):1102-8. [Medline].

14. Moch H, Gasser T, Amin MB, Torhorst J, Sauter G, Mihatsch MJ. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer. 2000 Aug 1. 89(3):604-14. [Medline].

15. Amin MB, Amin MB, Tamboli P, Javidan J, Stricker H, de-Peralta Venturina M, et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am J Surg Pathol. 2002 Mar. 26(3):281-91. [Medline].

16. Delahunt B. Sarcomatoid renal carcinoma: the final common dedifferentiation pathway of renal epithelial malignancies. Pathology. 1999 Aug. 31(3):185-90. [Medline].

17. Kuroda N, Toi M, Hiroi M, Enzan H. Review of sarcomatoid renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol. 2003 Apr. 18(2):551-5. [Medline].

18. Farrow GM, Harrison EG Jr, Utz DC. Sarcomas and sarcomatoid and mixed malignant tumors of the kidney in adults. 3. Cancer. 1968 Sep. 22(3):556-63. [Medline].

19. Jones TD, Eble JN, Wang M, Maclennan GT, Jain S, Cheng L. Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation. Cancer. 2005 Sep 15. 104(6):1195-203. [Medline].

20. McLaughlin JK, Lipworth L, Tarone RE. Epidemiologic aspects of renal cell carcinoma. Semin Oncol. 2006 Oct. 33(5):527-33. [Medline].

21. Decastro GJ, McKiernan JM. Epidemiology, clinical staging, and presentation of renal cell carcinoma. Urol Clin North Am. 2008 Nov. 35(4):581-92; vi. [Medline].

22. Pascual D, Borque A. Epidemiology of kidney cancer. Adv Urol. 2008. 782381. [Medline]. [Full Text].

23. Wallace AC, Nairn RC. Renal tubular antigens in kidney tumors. Cancer. 1972 Apr. 29(4):977-81. [Medline].

24. Delahunt B, Eble JN. History of the development of the classification of renal cell neoplasia. Clin Lab Med. 2005 Jun. 25(2):231-46, v. [Medline].

25. Prasad SR, Narra VR, Shah R, Humphrey PA, Jagirdar J, Catena JR, et al. Segmental disorders of the nephron: histopathological and imaging perspective. Br J Radiol. 2007 Aug. 80(956):593-602. [Medline].

26. Dall'Oglio MF, Lieberknecht M, Gouveia V, Sant'Anna AC, Leite KR, Srougi M. Sarcomatoid differentiation in renal cell carcinoma: prognostic implications. Int Braz J Urol. 2005 Jan-Feb. 31(1):10-6. [Medline].

27. Bonsib SM. T2 clear cell renal cell carcinoma is a rare entity: a study of 120 clear cell renal cell carcinomas. J Urol. 2005 Oct. 174(4 Pt 1):1199-202; discussion 1202. [Medline].

28. Margulis V, Tamboli P, Matin SF, Swanson DA, Wood CG. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma. Cancer. 2008 Apr 1. 112(7):1480-8. [Medline].

29. Green FL, Page D, Morrow M. AJCC cancer staging manual. 6th ed. New York: Springer; 2002.

30. Ro JY, Ayala AG, Sella A, Samuels ML, Swanson DA. Sarcomatoid renal cell carcinoma: clinicopathologic. A study of 42 cases. Cancer. 1987 Feb 1. 59(3):516-26. [Medline].

31. Castillo M, Petit A, Mellado B, Palacín A, Alcover JB, Mallofré C. C-kit expression in sarcomatoid renal cell carcinoma: potential therapy with imatinib. J Urol. 2004 Jun. 171(6 Pt 1):2176-80. [Medline].

32. Kwak C, Park YH, Jeong CW, Jeong H, Lee SE, Moon KC, et al. Sarcomatoid differentiation as a prognostic factor for immunotherapy in metastatic renal cell carcinoma. J Surg Oncol. 2007 Mar 15. 95(4):317-23. [Medline].

33. Bonsib SM, Fischer J, Plattner S, Fallon B. Sarcomatoid renal tumors. Clinicopathologic correlation of three cases. Cancer. 1987 Feb 1. 59(3):527-32. [Medline].

34. Morikawa Y, Tohya K, Kusuyama Y, Masui M, Wakasugi C. Sarcomatoid renal cell carcinoma. An immunohistochemical and ultrastructural study. Int Urol Nephrol. 1993. 25(1):51-8. [Medline].

35. Krishnan B, Truong LD. Renal epithelial neoplasms: the diagnostic implications of electron microscopic study in 55 cases. Hum Pathol. 2002 Jan. 33(1):68-79. [Medline].

36. Weeks DA, Beckwith JB, Mierau GW, Luckey DW. Rhabdoid tumor of kidney. A report of 111 cases from the National Wilms' Tumor Study Pathology Center. Am J Surg Pathol. 1989 Jun. 13(6):439-58. [Medline].

37. DeLong W, Grignon DJ, Eberwein P, Shum DT, Wyatt JK. Sarcomatoid renal cell carcinoma. An immunohistochemical study of 18 cases. Arch Pathol Lab Med. 1993 Jun. 117(6):636-40. [Medline].

38. Akhtar M, Tulbah A, Kardar AH, Ali MA. Sarcomatoid renal cell carcinoma: the chromophobe connection. Am J Surg Pathol. 1997 Oct. 21(10):1188-95. [Medline].

39. Brunelli M, Gobbo S, Cossu-Rocca P, Cheng L, Hes O, Delahunt B, et al. Chromosomal gains in the sarcomatoid transformation of chromophobe renal cell carcinoma. Mod Pathol. 2007 Mar. 20(3):303-9. [Medline].

40. Tretiakova MS, Sahoo S, Takahashi M, Turkyilmaz M, Vogelzang NJ, Lin F, et al. Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma. Am J Surg Pathol. 2004 Jan. 28(1):69-76. [Medline].

41. Wang J, Weiss LM, Hu B, Chu P, Zuppan C, Felix D, et al. Usefulness of immunohistochemistry in delineating renal spindle cell tumours. A retrospective study of 31 cases. Histopathology. 2004 May. 44(5):462-71. [Medline].

42. Furlong MA, Mentzel T, Fanburg-Smith JC. Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers. Mod Pathol. 2001 Jun. 14(6):595-603. [Medline].

43. Nikaido T, Nakano M, Kato M, Suzuki M, Ishikura H, Aizawa S. Characterization of smooth muscle components in renal angiomyolipomas: Histological and immunohistochemical comparison with renal capsular leiomyomas. Pathol Int. 2004 Jan. 54(1):1-9. [Medline].

44. Perez-Montiel D, Wakely PE, Hes O, Michal M, Suster S. High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants. Mod Pathol. 2006 Apr. 19(4):494-503. [Medline].

45. Shannon B, Stan Wisniewski Z, Bentel J, Cohen RJ. Adult rhabdoid renal cell carcinoma. Arch Pathol Lab Med. 2002 Dec. 126(12):1506-10. [Medline].

46. Bourdeaut F, Fréneaux P, Thuille B, Lellouch-Tubiana A, Nicolas A, Couturier J, et al. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities. J Pathol. 2007 Feb. 211(3):323-30. [Medline].

47. Perry A, Fuller CE, Judkins AR, Dehner LP, Biegel JA. INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas. Mod Pathol. 2005 Jul. 18(7):951-8. [Medline].

48. Hoot AC, Russo P, Judkins AR, Perlman EJ, Biegel JA. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am J Surg Pathol. 2004 Nov. 28(11):1485-91. [Medline].

49. Oda H, Nakatsuru Y, Ishikawa T. Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas. Cancer Res. 1995 Feb 1. 55(3):658-62. [Medline].

50. Dal Cin P, Sciot R, Van Poppel H, Balzarini P, Roskams T, Van den Berghe H. Chromosome changes in sarcomatoid renal carcinomas are different from those in renal cell carcinomas. Cancer Genet Cytogenet. 2002 Apr 1. 134(1):38-40. [Medline].

51. Presti JC Jr, Rao PH, Chen Q, Reuter VE, Li FP, Fair WR, et al. Histopathological, cytogenetic, and molecular characterization of renal cortical tumors. Cancer Res. 1991 Mar 1. 51(5):1544-52. [Medline].

52. Cohen RJ, McNeal JE, Susman M, Sellner LN, Iacopetta BJ, Weinstein SL, et al. Sarcomatoid renal cell carcinoma of papillary origin. A case report and cytogenic evaluation. Arch Pathol Lab Med. 2000 Dec. 124(12):1830-2. [Medline].

53. Biegel JA, Tan L, Zhang F, Wainwright L, Russo P, Rorke LB. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res. 2002 Nov. 8(11):3461-7. [Medline].

54. Ito T, Pei J, Dulaimi E, Menges C, Abbosh PH, Smaldone MC, et al. Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid Features. J Urol. 2015 Nov 18. [Medline].

55. Bonsib SM. The renal sinus is the principal invasive pathway: a prospective study of 100 renal cell carcinomas. Am J Surg Pathol. 2004 Dec. 28(12):1594-600. [Medline].

56. Peña-Llopis S, Vega-Rubín-de-Celis S, Liao A, Leng N, Pavía-Jiménez A, Wang S. BAP1 loss defines a new class of renal cell carcinoma. Nat Genet. 2012 Jul. 44(7):751-9. [Medline].

57. Nanus DM, Garino A, Milowsky MI, Larkin M, Dutcher JP. Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma. Cancer. 2004 Oct 1. 101(7):1545-51. [Medline].

58. Golshayan AR, George S, Heng DY, Elson P, Wood LS, Mekhail TM, et al. Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy. J Clin Oncol. 2009 Jan 10. 27(2):235-41. [Medline].

59. Upton MP, Parker RA, Youmans A, McDermott DF, Atkins MB. Histologic predictors of renal cell carcinoma response to interleukin-2-based therapy. J Immunother. 2005 Sep-Oct. 28(5):488-95. [Medline].

60. Shannon BA, Murch A, Cohen RJ. Primary renal synovial sarcoma confirmed by cytogenetic analysis: a lesion distinct from sarcomatoid renal cell carcinoma. Arch Pathol Lab Med. 2005 Feb. 129(2):238-40. [Medline].

Ronald J Cohen, MB, BCh, PhD, FRCPA, FFPATH Director of Pathology, Uropath Pty Ltd; Clinical Professor, School of Pathology and Laboratory Medicine, University of Western Australia, Australia

Ronald J Cohen, MB, BCh, PhD, FRCPA, FFPATH is a member of the following medical societies: Royal College of Pathologists of Australasia

Disclosure: Nothing to disclose.

Liang Cheng, MD Virgil H Moon Professor of Pathology and Laboratory Medicine, Professor of Urology, Director of Molecular Diagnostics and Molecular Pathology Laboratory, Indiana University School of Medicine; Chief, Genitourinary Pathology Service, Indiana University Health

Liang Cheng, MD is a member of the following medical societies: American Association for Cancer Research, American Urological Association, Arthur Purdy Stout Society, College of American Pathologists, International Society of Urological Pathology, United States and Canadian Academy of Pathology

Disclosure: Nothing to disclose.